Search research articles
Contact Us
Filters
Showing results (761-770 of 1,158) with videos related to
Page
of 116
Sort By:
Thorax
|
September 14, 2013
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
Gregory J Keir, Benjamin Garfield, David M Hansell, et al.
Respiratory Research
|
July 16, 2026
Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA<sub>1</sub> antagonism: exploratory analysis from a phase 2 trial of admilparant
Toby M Maher, Naftali Kaminski, Fang Wang, et al.
Maternal and Child Health Journal
|
April 13, 2020
The Association Between Preeclampsia and Childhood Development and Behavioural Outcomes
Gillian M Maher, Gerard W O'Keeffe, Linda M O'Keeffe, et al.
ACR Open Rheumatology
|
July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
Shervin Assassi, Oliver Distler, Yannick Allanore, et al.
BMJ Open Respiratory Research
|
September 21, 2018
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
Toby M Maher, Tamera J Corte, Aryeh Fischer, et al.
Insights Into Imaging
|
August 10, 2014
Medical student knowledge regarding radiology before and after a radiological anatomy module: implications for vertical integration and self-directed learning
Kevin P Murphy, Lee Crush, Eoin O'Malley, et al.
Pharmacology & Therapeutics
|
December 28, 2020
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
Paolo Spagnolo, Jonathan A Kropski, Mark G Jones, et al.
American Journal of Obstetrics and Gynecology
|
November 5, 2021
Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis
Sukainah Al Khalaf, Elizabeth Bodunde, Gillian M Maher, et al.
Journal of Comparative Effectiveness Research
|
December 20, 2022
Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis
Luca Richeldi, Arata Azuma, Vincent Cottin, et al.
Archives of Biochemistry and Biophysics
|
February 10, 2011
Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages
Nobuhiko Harada, Masaya Kanayama, Atsushi Maruyama, et al.
Page
of 116
Search research articles
Search
Showing results (761-770 of 1,158) with videos related to
Sort By:
Page
of 116
Thorax
|
September 14, 2013
Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis
Gregory J Keir, Benjamin Garfield, David M Hansell, et al.
Respiratory Research
|
July 16, 2026
Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA<sub>1</sub> antagonism: exploratory analysis from a phase 2 trial of admilparant
Toby M Maher, Naftali Kaminski, Fang Wang, et al.
Maternal and Child Health Journal
|
April 13, 2020
The Association Between Preeclampsia and Childhood Development and Behavioural Outcomes
Gillian M Maher, Gerard W O'Keeffe, Linda M O'Keeffe, et al.
ACR Open Rheumatology
|
July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial
Shervin Assassi, Oliver Distler, Yannick Allanore, et al.
BMJ Open Respiratory Research
|
September 21, 2018
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
Toby M Maher, Tamera J Corte, Aryeh Fischer, et al.
Insights Into Imaging
|
August 10, 2014
Medical student knowledge regarding radiology before and after a radiological anatomy module: implications for vertical integration and self-directed learning
Kevin P Murphy, Lee Crush, Eoin O'Malley, et al.
Pharmacology & Therapeutics
|
December 28, 2020
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
Paolo Spagnolo, Jonathan A Kropski, Mark G Jones, et al.
American Journal of Obstetrics and Gynecology
|
November 5, 2021
Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis
Sukainah Al Khalaf, Elizabeth Bodunde, Gillian M Maher, et al.
Journal of Comparative Effectiveness Research
|
December 20, 2022
Plain language summary: Clinical study of BI 1015550 as a potential treatment for idiopathic pulmonary fibrosis
Luca Richeldi, Arata Azuma, Vincent Cottin, et al.
Archives of Biochemistry and Biophysics
|
February 10, 2011
Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages
Nobuhiko Harada, Masaya Kanayama, Atsushi Maruyama, et al.
Page
of 116